• / Free eNewsletters & Magazine
  • / My Account
Home>Research & Insights>Investment Insights>Buy the Funds, Not the Stock

Related Content

  1. Videos
  2. Articles
  1. When Managers Change, So Can Ratings

    Recent manager changes at T . Rowe and Janus resulted in Analyst Rating downgrades, says Morningstar's Russ Kinnel.

Buy the Funds, Not the Stock

Do fund company shares really outperform the fund companies' funds? 

Russel Kinnel, 12/05/2011

About 10 years ago, there were a few articles written that pointed out the intriguing fact that an investor would have been much better off buying shares of fund companies than their funds. Some then concluded that it reflected that fund company management's true loyalties were to stockholders rather than to fundholders. Others saw it as proof that funds were just for naïve small investors who were ripe to get ripped off.

To be sure, there are some areas where the interests of fund company stockholders and fundholders are aligned. To produce strong stock appreciation at an asset manager you almost certainly need to produce superior long-term performance for fundholders first. In other ways, those interests conflict. If a fund company holds off on closing a fund in order to garner more assets, it boosts its earnings in the short run at the very least, yet is sacrificing long-term returns for fundholders. Likewise, a fund company sees a short-term benefit to keeping fees high, which detracts 1-for-1 from fundholders' bottom line. However, in the long run, high fees inevitably lead to poor long-term performance and, in turn, redemptions that cost the fund company money.

Some fund company shares have been poor performers in recent years, so I was curious if the tables had turned on asset manager stocks versus funds. I looked at 10-year performance through Oct. 31, 2011, of asset-manager stocks, their funds, and their stock funds to see how things shook out. I excluded fund companies where the fund business is a small sliver of a giant bank or insurance company as you can't really read much into that. That left me with 12 fund companies that provided a valid comparison.

Funds vs. Fund Company Stock

This time out the tables had indeed turned. At eight of the 12 fund companies, the funds--whether pure equity or all funds--beat the company shares and quite handily, too. The most extreme case was Janus JNS where the average fund returned an annualized 5.9% while the stock lost 9.9%. (All return figures here are annualized.) The figures are very similar if you limit it to stock funds (5.9%) or asset weight all funds (5.1%), or just stock funds (5.0%). Likewise, shares of AllianceBernstein AB lost 2%, while its average fund returned 4.9% and the average stock fund returned 5.4%.

The worst asset-weighted returns belonged to Legg Mason LM, with a mere 2.6%, but that still beat its stock return of 1.4%. So, both stockholders and fundholders have reason to be disgruntled. On the flip side, T. Rowe Price TROW had the best stock performance and the greatest outperformance of stock versus funds. Yet its fund performance was also the best. T. Rowe shares returned 15.7% annualized and its funds returned an asset-weighted 6.8%. The examples of T. Rowe Price and Legg Mason illustrate that there certainly is a positive link between fund performance and fund company stock performance. Serve fund investors well and you'll draw assets and likely boost your stock performance.

While Janus' example would seem to contradict this case, it really doesn't. Ten years ago, expectations for Janus stock and funds were sky high as indicated by fund flows. Yet Janus bitterly disappointed with poor losses in the 2000-02 bear market and then by getting ensnared in the market-timing scandal. That led to huge outflows. On the positive side, the firm has actually delivered pretty good results the past 10 years--only it hasn't spurred much inflows and that's reflected in its stock price, which now reflects very low expectations. (I can see why Greggory Warren has it rated 4 stars and why John Rogers owns the stock in Ariel Fund ARGFX.)

Russel Kinnel is Morningstar's director of mutual fund research. He is also the editor of Morningstar FundInvestor, a monthly newsletter dedicated to helping investors pick great mutual funds, build winning portfolios, and monitor their funds for greater gains. (Click here for a free issue). Mr. Kinnel would like to hear from readers, but no financial-planning questions, please. Follow Russel on Twitter: @russkinnel.
blog comments powered by Disqus
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.